Endourological Management of Stones During COVID19

NCT ID: NCT05293262

Last Updated: 2022-03-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

158 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-23

Study Completion Date

2020-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Guidelines for endourological procedures during COVID-19 have suggested deferring all elective procedures, while obstructed/ infected stones should undergo urgent decompression.

At our centre, screening protocols were implemented with prioritization strategies so that elective care could safely continue at deescalated rates. COVID or septic patients underwent emergency decompression, while non-COVID and non-septic patients underwent primary ureteroscopy (URS) or retrograde intrarenal surgery (RIRS).

We aim to report our experience with endourological surgery for stone disease during COVID-19.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We conducted a retrospective review of a prospectively maintained database of all endourological surgeries for stones in our centre during the first wave of COVID19.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urolithiasis COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients who underwent endourological surgery for urolithiasis during COVID19

Endourological surgery (including ureteral stent insertion, ureteroscopy, retrograde intrarenal surgery)

Endourological surgery

Intervention Type PROCEDURE

Includes ureteral stent insertion, ureteroscopies and retrograde intrarenal surgeies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endourological surgery

Includes ureteral stent insertion, ureteroscopies and retrograde intrarenal surgeies

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- all patient with urolithiasis who underwent endourological interventions during COVID19 pandemic
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Roxanne Teo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Roxanne Teo

Medical Officer

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chin Tiong Heng

Role: PRINCIPAL_INVESTIGATOR

Ng Teng Fong General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ng Teng Fong General Hospital, Singapore

Singapore, , Singapore

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Singapore

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020/01298

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Struvite Stones Antibiotic Study
NCT02375295 UNKNOWN PHASE4